6229 related articles for article (PubMed ID: 18650914)
21. Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions.
Apte RN; Krelin Y; Song X; Dotan S; Recih E; Elkabets M; Carmi Y; Dvorkin T; White RM; Gayvoronsky L; Segal S; Voronov E
Eur J Cancer; 2006 Apr; 42(6):751-9. PubMed ID: 16530403
[TBL] [Abstract][Full Text] [Related]
22. Modulation of inflammatory genes by natural dietary bioactive compounds.
Pan MH; Lai CS; Dushenkov S; Ho CT
J Agric Food Chem; 2009 Jun; 57(11):4467-77. PubMed ID: 19489612
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory signaling cascades and autophagy in cancer.
Monkkonen T; Debnath J
Autophagy; 2018; 14(2):190-198. PubMed ID: 28813180
[TBL] [Abstract][Full Text] [Related]
24. Tumor-host interactions: the role of inflammation.
Le Bitoux MA; Stamenkovic I
Histochem Cell Biol; 2008 Dec; 130(6):1079-90. PubMed ID: 18953558
[TBL] [Abstract][Full Text] [Related]
25. Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity.
Njunge LW; Estania AP; Guo Y; Liu W; Yang L
Theranostics; 2020; 10(18):8343-8364. PubMed ID: 32724474
[TBL] [Abstract][Full Text] [Related]
26. Cellular and molecular pathways linking inflammation and cancer.
Porta C; Larghi P; Rimoldi M; Totaro MG; Allavena P; Mantovani A; Sica A
Immunobiology; 2009; 214(9-10):761-77. PubMed ID: 19616341
[TBL] [Abstract][Full Text] [Related]
27. Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment.
Attiq A; Afzal S
Front Pharmacol; 2023; 14():1255727. PubMed ID: 37680708
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms linking pathogens-associated inflammation and cancer.
Porta C; Riboldi E; Sica A
Cancer Lett; 2011 Jun; 305(2):250-62. PubMed ID: 21093147
[TBL] [Abstract][Full Text] [Related]
29. Oncogene and non-oncogene addiction in inflammation-associated cancers.
Zheng M; Jiang J; Tang YL; Liang XH
Future Oncol; 2013 Apr; 9(4):561-73. PubMed ID: 23560378
[TBL] [Abstract][Full Text] [Related]
30. Role of inflammatory cells and mediators in tumor invasion and metastasis.
Mantovani A
Cancer Metastasis Rev; 2010 Jun; 29(2):241. PubMed ID: 20397039
[No Abstract] [Full Text] [Related]
31. The tumor microenvironment and its contribution to tumor evolution toward metastasis.
Lorusso G; Rüegg C
Histochem Cell Biol; 2008 Dec; 130(6):1091-103. PubMed ID: 18987874
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
Bild AH; Yao G; Chang JT; Wang Q; Potti A; Chasse D; Joshi MB; Harpole D; Lancaster JM; Berchuck A; Olson JA; Marks JR; Dressman HK; West M; Nevins JR
Nature; 2006 Jan; 439(7074):353-7. PubMed ID: 16273092
[TBL] [Abstract][Full Text] [Related]
33. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.
Yu H; Kortylewski M; Pardoll D
Nat Rev Immunol; 2007 Jan; 7(1):41-51. PubMed ID: 17186030
[TBL] [Abstract][Full Text] [Related]
34. The fundamental role of mechanical properties in the progression of cancer disease and inflammation.
Mierke CT
Rep Prog Phys; 2014 Jul; 77(7):076602. PubMed ID: 25006689
[TBL] [Abstract][Full Text] [Related]
35. Inflammation and cancer revisited: an hypothesis on the oncogenic potential of the apoptotic tumor cell.
Gregory CD
Autoimmunity; 2013 Aug; 46(5):312-6. PubMed ID: 23320865
[TBL] [Abstract][Full Text] [Related]
36. Function of oncogenes in cancer development: a changing paradigm.
Vicente-Dueñas C; Romero-Camarero I; Cobaleda C; Sánchez-García I
EMBO J; 2013 May; 32(11):1502-13. PubMed ID: 23632857
[TBL] [Abstract][Full Text] [Related]
37. An inflammatory vicious cycle: Fibroblasts and immune cell recruitment in cancer.
Raz Y; Erez N
Exp Cell Res; 2013 Jul; 319(11):1596-603. PubMed ID: 23567181
[TBL] [Abstract][Full Text] [Related]
38. Inflammation markers in cutaneous melanoma - edgy biomarkers for prognosis.
Neagu M; Constantin C; Dumitrascu GR; Lupu AR; Caruntu C; Boda D; Zurac S
Discoveries (Craiova); 2015 Mar; 3(1):e38. PubMed ID: 32309563
[TBL] [Abstract][Full Text] [Related]
39. Tumour Biology: tumour-associated inflammation versus antitumor immunity.
Müller-Hübenthal B; Azemar M; Lorenzen D; Huber M; Freudenberg MA; Galanos C; Unger C; Hildenbrand B
Anticancer Res; 2009 Nov; 29(11):4795-805. PubMed ID: 20032438
[TBL] [Abstract][Full Text] [Related]
40. Isolation of inflammatory cells from human tumours.
Polak ME
Methods Mol Biol; 2011; 731():201-8. PubMed ID: 21516409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
